A team of researchers has designed a computational method to determine the progression of colorectal cancer, a scientific breakthrough that may open new perspectives regarding the factors that enhance...
Read moreReceiving 6 M EUR in funding from the European Commission´s Horizon 2020 – the biggest EU Research and Innovation Programme, MoTriColor will conduct early phase clinical trials in colorectal cancer...
Read moreResearch into the Wnt/β-catenin signalling pathway is nothing new – it has been the focus of intense study for many years. Despite such exhaustive efforts, the first effective drugs for blocking th...
Read moreThe CORRECT study, published ahead of print online today in The Lancet Oncology, is one of the largest trials to date comparing data provided by liquid versus tissue biopsy in metastatic colorectal ca...
Read moreLas seis mutaciones identificadas por los oncólogos del Hospital del Mar sobre el gen EFGR, publicadas en la revista Clinical Cancer Research, tienen mecanismos de resistencia al fármaco cetuximab
Read moreThe results of this trial, although modest in terms of benefit, are important since they offer these patients an alternative therapy against the advancement of their disease – whereas previously no ...
Read moreMCRS1 protein, in response to an excess of nutrients, induces an increase in the activity of mTOR (the mamm alian/mechanistic Target of Rapamycin); a protein that is altered in human diseases such as ...
Read moreScientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death
Read more